Vanguard S&P 500 ETF (VOO)
483.90
+0.67 (0.14%)
NYSE · Last Trade: Apr 18th, 7:31 PM EDT
Detailed Quote
Previous Close | 483.23 |
---|---|
Open | 484.79 |
Day's Range | 481.50 - 488.16 |
52 Week Range | 442.80 - 563.92 |
Volume | 5,639,456 |
Market Cap | 5.71B |
Dividend & Yield | 6.556 (1.35%) |
1 Month Average Volume | 11,814,851 |
Chart
News & Press Releases
Nixon's historic announcement on Aug 15, 1971 to suspend convertibility of US dollar into gold marked the end of Bretton Woods system.
Via Benzinga · April 18, 2025
Via The Motley Fool · April 18, 2025
The health insurer’s Q1 adjusted earnings guidance of $11.97 per diluted share exceeds an analyst estimate of $11.38, as per FinChat data.
Via Stocktwits · April 17, 2025
Total assets under management rose 10% YoY to $1.17 trillion, with the quarter seeing inflows of $61.6 billion.
Via Stocktwits · April 17, 2025
Total revenue rose 7% year-over-year to $16.97 billion, surpassing a Street estimate of $16.93 billion.
Via Stocktwits · April 17, 2025
The insurance company now sees full-year adjusted earnings per share between $26 and $26.50, down from its previous forecast of $29.50 to $30, and below an analyst estimate of $29.74, as per FinChat data.
Via Stocktwits · April 17, 2025
Via The Motley Fool · April 17, 2025
Financial influencer Gav Blaxberg offers valuable insights on why tariffs will have zero long-term impact on the stock market.
Via Benzinga · April 16, 2025
Ford assembles its Lincoln Nautilus in China and exports it into the U.S. market; the company sold 36,544 vehicle units in the U.S. last year.
Via Stocktwits · April 16, 2025
Abbott reaffirmed its full-year 2025 financial guidance and expects full-year 2025 adjusted diluted earnings per share of $5.05 to $5.25.
Via Stocktwits · April 16, 2025
The Federal Deposit Insurance Corp. initially sought approximately $1 billion in unpaid assessments and another $1 billion in alleged profits from underreporting risk in its lawsuit against the Bank of America.
Via Stocktwits · April 15, 2025
Provision for credit losses increased to $219 million during the quarter from $155 million in the same period a year ago, reflecting changes in macroeconomic factors and portfolio activity.
Via Stocktwits · April 15, 2025
Total revenues rose 3% year-over-year to $21.59 billion compared to a Wall Street estimate of $21.29 billion, driven by growth in each of Citi’s five interconnected businesses.
Via Stocktwits · April 15, 2025
Revenue rose 6% year-over-year to $27.4 billion during the quarter, compared to a Wall Street estimate of $26.91 billion.
Via Stocktwits · April 15, 2025
The company said the updated guidance includes costs estimated to be incurred as part of Trump’s tariffs on certain imports into the U.S.
Via Stocktwits · April 15, 2025
Wall Street expects the lender to post earnings of $1.85 per share for the first quarter on revenue of $21.29 billion.
Via Stocktwits · April 15, 2025
Forward P/E ratios have come down. But is the E accurate? From Sam Ro, who was featured in CNN's Reliable Sources newsletter this past Friday.
Via Benzinga · April 14, 2025
Intel will own the remaining 49% of the business, enabling it to participate in Altera’s future success while focusing on its core business.
Via Stocktwits · April 14, 2025
Investing might look easy for some, but that isn’t always the case.
Via Benzinga · April 14, 2025
Palantir’s Maven Smart System NATO (MSS NATO) will be employed within NATO’s Allied Command Operations (ACO), enabling a significant advancement in the modernization of its warfighting capabilities.
Via Stocktwits · April 14, 2025
The 90-day tariff pause may offer temporary relief, but macro backdrop remains fragile. JPMorgan warns of recession risk and trimmed S&P 500 target.
Via Benzinga · April 14, 2025
Total revenue rose 6% year over year to $15.06 billion and surpassed an analyst estimate of $14.71 billion, led by higher net revenues in Global Banking & Markets but partially offset by slightly lower net revenues in Asset & Wealth Management.
Via Stocktwits · April 14, 2025
Sandoz is seeking an injunction to prevent Amgen from using patent rights to block biosimilar competition and allow Sandoz to launch its Erelzi “as soon as possible.”
Via Stocktwits · April 14, 2025